NACDS, NCPA Praise Senate Action to Reduce Patient Drug Costs Bipartisan Senate letter to HHS Secretary urges swift action on pharmacy DIR fee reform to lower out-of-pocket drug costs for patients and to stop unworkable practices that are unfair to pharmacies

2019-02-05T10:19:20-05:00Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.

At the White House’s Invitation, NACDS Participates in Bill Signing Ceremony for “Gag Clause” Prohibition NACDS applauds Trump Administration’s focus on reducing patients’ out-of-pocket prescription drug costs, and Congressional sponsors’ effectiveness in advancing legislation

2018-10-10T14:10:29-04:00Categories: Press Release|Tags: , , |

NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.

House Sends NACDS-Backed “Gag Clause” Prohibition to President Legislation prevents restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance;NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs

2018-09-25T17:03:37-04:00Categories: Press Release|Tags: , , |

The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.

Go to Top